GARVEY DAVID S has a total of 19 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are RESFAR SRL, SYNTA PHARMACEUTICALS and CHROMA THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 12 | |
#2 | United States | 7 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Peptides | |
#6 | Organic chemistry methods | |
#7 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Garvey David S | 19 |
#2 | Worcel Manuel | 3 |
#3 | Letts L Gordon | 3 |
#4 | Ranatunge Ramani R | 3 |
#5 | Richardson Stewart K | 2 |
#6 | Letts Gordon L | 2 |
#7 | Tejada Inigo S D | 1 |
#8 | Berman Judd | 1 |
#9 | Gaston Ricky D | 1 |
#10 | Côté Jamie B | 1 |
Publication | Filing date | Title |
---|---|---|
US2009203653A1 | Compositions and methods using apocynin compounds and nitric oxide donors | |
US2006063774A1 | Phosphodiesterase inhibitor compounds and nitric oxide donors | |
WO2005018561A2 | Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use | |
WO2004060283A2 | Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use | |
WO03103602A2 | Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |